Blood‑based biomarkers are reshaping Alzheimer’s trials by enabling earlier, cheaper identification. Could these enrolment strategies translate to other slow‑progressing diseases? ICON experts share their insight in the ...
Thank you for your interest in ICON services. Please complete the form below providing details of your request, which will be sent to a member of staff for immediate review.
This form only accepts qualified proposal requests for ICON services. All other enquires should be directed to our Contact page.